160 related articles for article (PubMed ID: 18583935)
21. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
[TBL] [Abstract][Full Text] [Related]
22. How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
Jorda R; Hendrychová D; Voller J; Řezníčková E; Gucký T; Kryštof V
J Med Chem; 2018 Oct; 61(20):9105-9120. PubMed ID: 30234987
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1.
Vassilev LT
Cell Cycle; 2006 Nov; 5(22):2555-6. PubMed ID: 17172841
[TBL] [Abstract][Full Text] [Related]
24. Rux is a cyclin-dependent kinase inhibitor (CKI) specific for mitotic cyclin-Cdk complexes.
Foley E; O'Farrell PH; Sprenger F
Curr Biol; 1999 Dec; 9(23):1392-402. PubMed ID: 10607563
[TBL] [Abstract][Full Text] [Related]
25. Distinct properties of cyclin-dependent kinase complexes containing cyclin A1 and cyclin A2.
Joshi AR; Jobanputra V; Lele KM; Wolgemuth DJ
Biochem Biophys Res Commun; 2009 Jan; 378(3):595-9. PubMed ID: 19056339
[TBL] [Abstract][Full Text] [Related]
26. 6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2.
Lee DE; Lee KW; Jung SK; Lee EJ; Hwang JA; Lim TG; Kim BY; Bode AM; Lee HJ; Dong Z
Carcinogenesis; 2011 Apr; 32(4):629-35. PubMed ID: 21258042
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of guanidino analogues of roscovitine.
Dolečková I; Cesnek M; Dračinský M; Brynda J; Voller J; Janeba Z; Kryštof V
Eur J Med Chem; 2013 Apr; 62():443-52. PubMed ID: 23399722
[TBL] [Abstract][Full Text] [Related]
28. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?
Wesierska-Gadek J; Krystof V
Ann N Y Acad Sci; 2009 Aug; 1171():228-41. PubMed ID: 19723060
[TBL] [Abstract][Full Text] [Related]
29. CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
Sunada S; Saito H; Zhang D; Xu Z; Miki Y
Biochem Biophys Res Commun; 2021 Apr; 550():56-61. PubMed ID: 33684621
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
David-Pfeuty T
Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
[TBL] [Abstract][Full Text] [Related]
31. Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex.
Gabrielli BG; Lee MS; Walker DH; Piwnica-Worms H; Maller JL
J Biol Chem; 1992 Sep; 267(25):18040-6. PubMed ID: 1517236
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases.
Vermeulen K; Strnad M; Krystof V; Havlícek L; Van der Aa A; Lenjou M; Nijs G; Rodrigus I; Stockman B; van Onckelen H; Van Bockstaele DR; Berneman ZN
Leukemia; 2002 Mar; 16(3):299-305. PubMed ID: 11896531
[TBL] [Abstract][Full Text] [Related]
33. Grapes(Chk1) prevents nuclear CDK1 activation by delaying cyclin B nuclear accumulation.
Royou A; McCusker D; Kellogg DR; Sullivan W
J Cell Biol; 2008 Oct; 183(1):63-75. PubMed ID: 18824564
[TBL] [Abstract][Full Text] [Related]
34. Cyclin E/Cdk2 is required for sperm maturation, but not DNA replication, in early sea urchin embryos.
Schnackenberg BJ; Palazzo RE; Marzluff WF
Genesis; 2007 May; 45(5):282-91. PubMed ID: 17458867
[TBL] [Abstract][Full Text] [Related]
35. Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit.
Potapova TA; Daum JR; Byrd KS; Gorbsky GJ
Mol Biol Cell; 2009 Mar; 20(6):1737-48. PubMed ID: 19158392
[TBL] [Abstract][Full Text] [Related]
36. Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.
Savio M; Cerri M; Cazzalini O; Perucca P; Stivala LA; Pichierri P; Franchitto A; Meijer L; Prosperi E
Cell Cycle; 2006 Sep; 5(18):2153-9. PubMed ID: 16969115
[TBL] [Abstract][Full Text] [Related]
37. Role for cyclin-dependent kinase 2 in mitosis exit.
D'Angiolella V; Costanzo V; Gottesman ME; Avvedimento EV; Gautier J; Grieco D
Curr Biol; 2001 Aug; 11(15):1221-6. PubMed ID: 11516956
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle sibling rivalry: Cdc2 vs. Cdk2.
Kaldis P; Aleem E
Cell Cycle; 2005 Nov; 4(11):1491-4. PubMed ID: 16258277
[TBL] [Abstract][Full Text] [Related]
39. Cdk1: unsung hero of S phase?
Pacek M; Prokhorova TA; Walter JC
Cell Cycle; 2004 Apr; 3(4):401-3. PubMed ID: 14752273
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
